CSD
NVACR

Clear Street Derivatives’s NorthView Acquisition Corporation Rights NVACR Stock Holding History

Clear Street Derivatives’s Portfolio NVACR Stock Details NVACR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-397,210
Closed -$20.3K – 91
2024
Q3 		$20.3K Hold
397,210
– – ﹤0.01% 54
2024
Q2 		$40.6K Hold
397,210
– – ﹤0.01% 38
2024
Q1 		$59.6K Buy
+397,210
New +$44.7K ﹤0.01% 36

Other funds holding NVACR

PL
Parkwood LLC Cleveland, Ohio $1.13B AUM 32.89% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return

Clear Street Derivatives's NVACR Position: Q4 2024 in Review

Clear Street Derivatives sold out of NorthView Acquisition Corporation Rights (NVACR) in Q4 2024, closing a stake of 397,210 shares — an estimated $20.3K sold.

Clear Street Derivatives first reported a position in NVACR in Q1 2024 and held it in 3 quarters. The position peaked at $59.6K in Q1 2024. 5 funds tracked by Wall St. Rank hold NVACR as of Q4 2024.

  • Clear Street Derivatives reported no remaining NorthView Acquisition Corporation Rights position as of Q4 2024 after selling out during the quarter.
  • Clear Street Derivatives sold 397,210 NorthView Acquisition Corporation Rights shares in Q4 2024, an estimated $20.3K.
  • Clear Street Derivatives first reported a position in NorthView Acquisition Corporation Rights in Q1 2024 and held it in 3 quarters.
  • Clear Street Derivatives's NorthView Acquisition Corporation Rights position peaked at $59.6K in Q1 2024.
  • 5 funds tracked by Wall St. Rank held NorthView Acquisition Corporation Rights as of Q4 2024.

Based on Clear Street Derivatives's 13F filing for Q4 2024, filed 14 Feb 2025.